Efficacy of immunotherapy in the treatment of asthma;Eficacia de la inmunoterapia en el tratamiento del asma

Allergologia et Immunopathologia

Volumn 32, Issue 3, 2004, Pages 133-141

  Martin Munoz Ma F ^a  

^a HOSPITAL INFANTIL LA PAZ   (Spain)

Author keywords

Allergy; Asthma; Immunotherapy

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; IMMUNOMODULATING AGENT; PLACEBO;

ALLERGIC RHINITIS; ASTHMA; AUTOIMMUNE DISEASE; BRONCHUS REACTIVITY; CANCER; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; ENVIRONMENTAL SANITATION; HEART DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; MEDICAL LITERATURE; PATIENT EDUCATION; PATIENT SELECTION; SIDE EFFECT; SPAIN; TREATMENT OUTCOME;

ADULT; ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; DESENSITIZATION, IMMUNOLOGIC; HUMANS; MITES; POLLEN; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 2542446379     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13060597     Document Type: Conference Paper

References (46)

1. Cookson WO. Asthma genetics. Chest 2002;121(3Suppl): 7S-13S.
2. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002;418:426-30.
3. Fenech A, All IP. Pharmacogenetics of asthma. Br J Clin Pharmacol 2002;53:3-15.
4. 2 adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75-80.
5. Palmer LJ, SilvermanES, Weis ST, Drazen JM. Pharmacogenetics of asthma. Am J Respir Crit Care Med 2002;165:861-6.
6. Cockroft DW. How west to measure airway responsiveness. Am J Respir Crit Care Med 2001;163:1514-5.
7. Vignola AM, Kips J, Bousquet J. Tissue remodelingas a feature of persistent asthma. J Allergy Clin Immunol 2000;105:1041-53.
8. Richter A, Puddicombe SM, Lordan JL, Bucchieri F, Wilsson SJ, Djukanovic R, et al. The contribution of interleukin (IL)-4 and IL-13 to the epithelial mesenchimal trophic unit in asthma. Am J Respir Crit Cell Mol Biol 2001;25:385-91.
9. Simons FER. Allergic rhinobronchitis: the asthma allergic rhinitis link. J Allergy Clin Immunol 1999;104:534-40.
10. Duff AL, Platts-Mills TAE. Allergens and asthma. Pediatr Clin North Am 1992;39:1277-91.
11. Green MN, Custovic A, Sanderson G et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002;324:763.
12. Rakes GP, Arruda E, Ingram JM, However GE, Zambrano JC, Hayden FG et al. Rhinovirus and respiratory syncitial virus in wheezing children requiring emergenci care: IgE and eosinofil analyses. Am J Respir Crit Care Med 1999;159:785-90.
13. Prophylactic inoculation agains hay fever. Lancet 1911;1:1572-3.
14. Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911;ii:814-7.
15. Durham S, Varney V, Gaga M, Frew A, Jacobson M, Kay A. Immunotherapy and allergic inflammation. Clin Exp Allergy 1991;21(Suppl 1:)206-10.
16. Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on celular infiltration and citokine mRNA expresión during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
17. Durham SR, Ying S, Varney VA et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4 + T lymphocytes and eosinophils in nasal mucosa and increases the number of cells expressing messenger RNA for interferon -gamma. J Allergy Clin Immunol 1996;97:1356-65.
18. Renz H, Lack G, Saloga J et al. Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen induced sensitization. J Immunol 1994;152:351-60.
19. Secrist H, Chelen CJ, Wen Y, Marshal JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4 + Tcells from allergic individuals. J Exp Med 1993;178:2123-30.
20. Secrist H, Dekruyff RH, Umetsu DT. Interleukin 4 production by CD4 + T cells from allergic individuals is modulated by antigen concentration and antigen presenting cell type. J Exp Med 1995;181:1081-9.
21. MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM. Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995;269:688-90.
22. Saxon A, Max EE, Diaz-Sánchez D, Zhang K. Alternative RNA of epsilon transcripts produces mRNAs encoding to membrana and f our secreted IgE isoforms. Int Arch Allergy Immunol 1995;107:45-7.
23. Otsuka H, Mezawa A, Ohnishi M, Okubo K, Seki H, Okuda M. Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy 1991;21:115-19.
24. Creticos PS, Adkinson N Jr, Kagey-Sobotka A, et al. Nasal challenge with regweedpollen in hay fever patients. Effect of immunotherapy. J Clin invest 1985;76:2247-53.
25. Furin MJ, Norman PS, Creticos PS et al. Immunoterapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin immunol 1991;88:27-32.
26. Iliopoulus O, Proud D, Adkinson N Jr et al. Effects of immunotherapy on the early, late and rechallenge nasal reaction to provocation whith allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991;87:855-66.
27. Cartier A, Thomson NC, Frith PA et al. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 1982;70:170.
28. Martín Muñoz F, Moreno Ancillo A, Pestaña JA, Contreras Porta J, Dfaz Pena JM, Ojeda JA. Atopy and Bronchial hyperresponsiveness in pure extrinsic childood asthma. J Investig Allergol Clin Immunol 1997;7:229-33.
29. Bousquet J, Chanez P, Lacoste JI et al. Asthma: a disease remodeling the airways. Allergy 1992;47:3-11.
30. Abramsson MJ, Puy RM, Weiner JM. Immunotherapy in asthma: an updated systematic review. Allergy 1999;54:1022-41.
31. Bousquet J, Becker WM, Hejjaoui A et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991;88:43-53.
32. Dreborj S, Agrell B, Foucard T, Kjellman NI, Koivikko A, Nilsson S. A double-blind, multicerter immunotherapy trial in children using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986;41:131-40.
33. Martín Muñoz MF. Inmunoterapia; Respuesta Clinica y Bronquial. Allergol Immunopatol 1996;24(Supl 1):68-79.
34. Bousquet J, Lockey RF, Malling HJ. WHO Position paper. Allergen Immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;44(Suppl 53:)5-41.
35. Anthony J, Frew MD. Immunotherapy of allergic disease. J Allergy Clin Immunol 2003;111:S712-9.
36. Citron K, Frankland A, Sinclair J. Inhalation tests of bronchial hypersensitivity in pollen asthma. Thorax 1958;13:229-32.
37. Hugo P, Van Bever, Stevens WnJ. Evolution of the late asmathic reaction during immunotherapy and after stopping immunotherapy. J Allergy Clin Immunol 1990;86:141-46. 201.
38. Metzger WJ, Donnelly A, Richerson HB. Modification of late asthmatic response (LAR) during immunotherapy for Alternaria-induced asthma. J Allergy Clin Immunol 1983;71:119.
39. Van Bever HP, Bosmans J, De Clerk LS, Stevens WJ. Modification of the late asthmatic reaction by hyposensitization in asthmatic allergic children to house dust mite (Dermatophagoides pteronyssinus) or grass pollen. Allergy 1988; 43:378-85.
40. Van Bever HP, Stevens VJ. Suppression of allergic to house dust mite. Clin Exp Immunol 1989;19:399-404.
41. Johnston DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children-a 14 year study. Pediatrics 1968;42,5:793-802.
42. Grammer LC, Shaugnessy MA, Suszko IM, Shaugnessy JJ, Patterson R. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study. J Allergy Clin Immunol 1984;73(4):484-9.
43. Jacobsen I, Nuchel Petersen B, Wihl JA, Lowenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6 year) follow-up. Allergy 1997;52(9):914-20.
44. Calvo M. Marin F. Grob K, Sanhueza Mkylling L, Albornoz C, Strikler A. Ten year follow-up in pediatric patients with allergic bronchial asthma: evaluation of specific immunotherapy. J Investig Allergol Clin Immunol 1994;4(3):126-31.
45. Shaikh WA. Immunotherapy vs inhaled budesonida in bronchial asthma: an open, parallel, comparative trial. Clinical & Experimental Allergy 1997;27(11):1279-84.
46. Heddling G, Heilborn H, Lilja G, Norrlind K, Pegelow KO, Schou C, Lowenstein H. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995;96(6 Pt 1):879-85.